Israel - English - Ministry of Health

novo nordisk ltd., israel - glucagon as hydrochloride - powder and solvent for solution for injection - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.

Canada - English - Health Canada

eli lilly and company limited - glucagon (glucagon hydrochloride) - powder for solution - 1mg - glucagon (glucagon hydrochloride) 1mg - glycogenolytic agents

United States - English - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - glucagon hydrochloride (unii: 1h87nvf4db) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagen is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. glucagen is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagen is contraindicated in patients with: risk summary available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. multiple small studies have demonstrated a lack of transfer of pancreatic glucagon across the human placental barrier during early gestation. in rat and rabbit reproduction studies, no embryofetal toxicity was observed with glucagon administered by injection during the period of organogenesis at doses representing up to 100 and 200 times the human dose, respectively, based on body surface area (mg/m2 ) (see data). the estimated background

United States - English - NLM (National Library of Medicine)

novo nordisk - glucagon hydrochloride (unii: 1h87nvf4db) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagen is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. glucagen is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagen is contraindicated in patients with: risk summary available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. multiple small studies have demonstrated a lack of transfer of pancreatic glucagon across the human placental barrier during early gestation. in rat and rabbit reproduction studies, no embryofetal toxicity was observed with glucagon administered by injection during the period of organogenesis at doses representing up to 100 and 200 times the human dose, respectively, based on body surface area (mg/m2 ) (see data). the estimated background

United States - English - NLM (National Library of Medicine)

amphastar pharmaceuticals, inc. - glucagon (unii: 76la80ig2g) (glucagon - unii:76la80ig2g) - become familiar with the following instructions before an emergency arises. do not use this kit after date stamped on the vial of glucagon. if you have questions concerning the use of this product, consult a doctor, nurse or pharmacist. make sure that your relatives or close friends know that if you become unconscious, medical assistance must always be sought. glucagon may have been prescribed so that members of your household can give the injection if you become severely hypoglycemic and are unable to take sugar by mouth. if you are unconscious, glucagon can be given while awaiting medical assistance. show your family members and others where you keep this kit and how to use it. they need to know how to use it before you need it. they can practice giving a shot by giving you your normal insulin shots. it is important that they practice. a person who has never given a shot probably will not be able to do it in an emergency. important - act quickly. prolonged unconsciousness may be harmful. - these simple inst

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) - solution for injection - 1 mg - active: glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) excipient: lactose monohydrate glycerol phenol water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - glucagon hydrochloride 10mg - injection with diluent - 10 mg - active: glucagon hydrochloride 10mg excipient: water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - glucagon hydrochloride 1mg - solution for injection - 1 mg - active: glucagon hydrochloride 1mg excipient: lactose monohydrate water for injection

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - glucagon (unii: 76la80ig2g) (glucagon - unii:76la80ig2g) - for temporary relief of symptoms related to low blood sugar levels, including lethargy, impaired mental function and irritability. for temporary relief of symptoms related to low blood sugar levels, including lethargy, impaired mental function and irritability.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

eli lilly and company - glucagon - powder for injection - 1 mg